Saturday 17 October 2026
Export QUCY’s income statement to Excel — free account
Quantum Cyber N.V
QUCY Healthcare Diagnostics & Research
Quantum Cyber N.V’s revenue for fiscal 2025 (year ended December 2025) was $537,100.00, down 39.9% from fiscal 2024. In the quarter to June 2026, EPS grew 96.0% and free cash flow grew 26.7%, each against the same quarter a year earlier.
1.08
0.01
−0.92%
Follow QUCY
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| (325.19%) | (552.83%) | 0.00% | 0.00% |
+8 more TTM periods Free account |
|
| (165.20%) | (186.52%) | 0.00% | 0.00% | ||
ROIC |
(193.99%) | (7,835.86%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(190.12%) | (620.52%) | 0.00% | 0.00% | |
Average Days of Receivables |
— | — | — | 0.00 | |
Free Cash Flow per Share |
(0.93) | (1.60) | — | 0.00 | |
Free Cash Flow |
(16.60) | (18.89) | — | (20.45) | |
Capital Expenditures |
(0.19) | (1.52) | — | (1.13) | |
| Other line items | |||||
Cash ROIC |
(49.21%) | (208.99%) | 0.00% | (339.94%) | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
— | — | — | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
— | — | — | 0.00 | |
Tax Rate |
0.00 | 0.00 | — | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | — | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | 0.00% | |
Operating CF/Net income |
0.62 | 0.81 | — | 0.00 | |
Depreciation/Fixed assets |
4.06 | 0.00 | — | 0.87 | |
Capex/Depreciation |
(0.34) | (1.44) | — | (0.94) | |
Revenue per Share |
0.00 | 0.00 | — | — | |
Operating CF per Share |
(0.92) | (1.47) | — | 0.00 | |
Capex per Share |
(0.01) | (0.13) | — | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 |
Columns are period end dates